<DOC>
	<DOCNO>NCT00103597</DOCNO>
	<brief_summary>Patients Parkinson 's Disease Multiple System Atrophy ( MSA ) , symptoms orthostatic hypotension , eligible study . Each patient three week conservative therapy , three week therapy fludrocortisone , three week therapy domperidone . Autonomic testing , symptom questionnaire , bedside blood pressure test , Unified Parkinson Disease Rating Scale ( UPDRS ) perform intervention .</brief_summary>
	<brief_title>Efficacy Therapeutic Interventions Orthostatic Hypotension Parkinson 's Disease Multiple System Atrophy</brief_title>
	<detailed_description>Enrolled patient , age 40-95 , must Parkinson 's MSA , diagnose neurologist , symptom orthostatic hypotension . Each patient fill two validate questionnaire determine candidate study . Baseline patient detail , medication UPDRS , record . Medications must hold stable period study . Each patient three week conservative therapy , three week therapy fludrocortisone , three week therapy domperidone . Autonomic testing , symptom questionnaire , bedside blood pressure test , UPDRS perform intervention .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Multiple System Atrophy</mesh_term>
	<mesh_term>Shy-Drager Syndrome</mesh_term>
	<mesh_term>Hypotension , Orthostatic</mesh_term>
	<mesh_term>Domperidone</mesh_term>
	<mesh_term>Fludrocortisone</mesh_term>
	<criteria>Patients reside Queensland Australia Age 4095 Parkinson 's Disease MSA diagnose neurologist Symptoms orthostatic hypotension , define 2 validated questionnaire Patients acute cardiomyopathy cardiac condition Patients unable give consent Patients stable Parkinsonian medication Patients another cause autonomic neuropathy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2005</verification_date>
	<keyword>Orthostatic hypotension</keyword>
	<keyword>Parkinson 's Disease</keyword>
</DOC>